Zacks Investment Research·Sep 17, 2026
Here's Why Aveanna Healthcare (AVAH) is a Great Momentum Stock to BuyDoes Aveanna Healthcare (AVAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Aveanna Healthcare is demonstrating accelerating revenue growth, reaching 13.7% year-over-year in 2026Q2, driven by an acquisition-heavy model that has expanded its scale. This top-line momentum has unlocked meaningful operating leverage, with the operating ma...
Price trend, volume and key moving averages
Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 13, 2026 | $0.22+30.7% vs $0.17 | $670M+5.0% vs $639M |
Q2 2026 May 14, 2026 | $0.18+38.5% vs $0.13 | $648M+5.7% vs $613M |
Q2 2026 Mar 19, 2026 | $0.17+10.5% vs $0.15 | $662M+3.0% vs $643M |
Q4 2025 Nov 6, 2025 | $0.15+87.5% vs $0.08 | $622M-4.2% vs $649M |
Does Aveanna Healthcare (AVAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Aveanna Healthcare Holdings Inc. (AVAH) Presents at Deutsche Bank 2026 Healthcare Summit Transcript
Aveanna (AVAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Hsbc Holdings PLC acquired a new position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 47,222 shares of the company's stock, valued at approximately $407,000. Other
Benchmark AVAH against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Aveanna Healthcare Holdings Inc. (AVAH)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $12.79 | $2.79B | 12.18 | 20.19% | 9.25% | 621.89% | — | |
| $39.65 | $1.38B | 47.20 | 36.31% | 2.93% | 8.55% | — | |
| $114.93 | $2.15B | 22.06 | 23.21% | 7.13% | 9.57% | — | |
| $21.25 | $1.46B | 26.23 | 7.08% | 6.59% | 24.12% | — | |
| $175.46 | $10.23B | 30.04 | 18.72% | 6.9% | 16.51% | — | |
| $53.79 | $2.83B | 9.76 | 2.36% | 7.07% | 21.72% | — |
Aveanna Healthcare Holdings Inc. (AVAH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Aveanna Healthcare Holdings Inc. (AVAH) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 24, 2026·SEC
Aug 13, 2026·SEC
Aug 13, 2026·SEC
Get notified when AVAH posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Aveanna Healthcare Holdings Inc. (AVAH) stock FAQ — growth, dividends, profitability & financials explained
Aveanna Healthcare Holdings Inc. (AVAH) reported $2.60B in revenue for fiscal year 2025. This represents a 108% increase from $1.25B in 2018.
Aveanna Healthcare Holdings Inc. (AVAH) grew revenue by 20.2% over the past year. This is strong growth.
Yes, Aveanna Healthcare Holdings Inc. (AVAH) is profitable, generating $274.8M in net income for fiscal year 2025 (9.2% net margin).
Aveanna Healthcare Holdings Inc. (AVAH) has a return on equity (ROE) of 621.9%. This is excellent, indicating efficient use of shareholder capital.
Aveanna Healthcare Holdings Inc. (AVAH) generated $165.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
